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Sox2 expression marks gastric stem and progenitor
cells, raising important questions regarding the
genes regulated by Sox2 and the role of Sox2 itself
during stomach homeostasis and disease. By using
ChIP-seq analysis, we have found that the majority
of Sox2 targets in gastric epithelial cells are tissue
specific and related to functions such as endoderm
development, Wnt signaling, and gastric cancer. Un-
expectedly, we found that Sox2 itself is dispensable
for gastric stem cell and epithelial self-renewal, yet
Sox2+ cells are highly susceptible to tumorigenesis
in an Apc/Wnt-driven mouse model. Moreover,
Sox2 loss enhances, rather than impairs, tumor for-
mation in Apc-deficient gastric cells in vivo and
in vitro by inducing Tcf/Lef-dependent transcription
and upregulating intestinal metaplasia-associated
genes, providing a mechanistic basis for the
observed phenotype. Together, these data identify
Sox2 as a context-dependent tumor suppressor pro-
tein that is dispensable for normal tissue regenera-
tion but restrains stomach adenoma formation
through modulation of Wnt-responsive and intestinal
genes.INTRODUCTION
Sox2 is a transcription factor that has been widely studied in the
context of development, pluripotency, and cellular reprogram-
ming (Sarkar and Hochedlinger, 2013). During development,
Sox2 controls the self-renewal and differentiation of a number
of embryo-derived stem cell populations, including embryonic
stem cells (ESCs) (Masui et al., 2007) and neural progenitor cells
(NPCs) (Graham et al., 2003). Consistent with this finding, chro-
matin immunoprecipitation sequencing (ChIP-seq) analyses inCell Re
This is an open access article under the CC BY-NESCs andNPCs indicate that Sox2 activates self-renewal genes,
while suppressing genes associated with differentiation (Lodato
et al., 2013). In addition to its role in development, Sox2 is ex-
pressed in a number of adult tissues, including the salivary gland,
uterus, anus, testes, and stomach, where it marks stem and pro-
genitor cell populations (Arnold et al., 2011). Whether Sox2
expression simply serves as a marker of adult stem and progen-
itor cells or is also functionally important remains largely unex-
plored. It is also unclear whether Sox2 targets similar or different
sets of genes in adult stem and progenitor cells compared to
ESCs to control self-renewal and differentiation. We chose the
glandular stomach as a model system to address some of these
questions as it constantly regenerates and contains a population
of Sox2+ stem and progenitor cells.
The gastric epithelium in mice and humans consists of flask-
like glandular units that contain mucus-, acid-, hormone-, and
enzyme-producing cells required to digest food (Mills and Shiv-
dasani, 2011). The glandular stomach is further subdivided into
the antrum and corpus, which exhibit different ratios of the four
principal cell types and distinct rates of epithelial turnover.
Sox2 is expressed at the base of antral glands, areas thought
to represent stem and progenitor cell compartments (Arnold
et al., 2011). Indeed, lineage-tracing experiments demonstrated
that the Sox2-expressing cells contain multipotent stem cells in
the glandular stomach (Arnold et al., 2011). However, the biolog-
ical role of Sox2 itself in this cell population remains to be
determined.
Gastric cancer is the third most frequent cause of cancer-
related deaths worldwide and is incurable when metastases
are present (Stewart et al., 2014). Although genome-wide
sequencing efforts have cataloged numerous gastric-cancer-
specificmutations, the functional significance of thesemutations
and the cell types in which they act remain unknown. Dysregula-
tion of Sox2 is associated with tumors in various tissues,
including the lung, esophagus, pituitary gland, skin, and retina
(Boumahdi et al., 2014; Kareta et al., 2015; Sarkar and Hoched-
linger, 2013; Bass et al., 2009). While SOX2 is overexpressed or
amplified in most of these tumors, consistent with an oncogenic
function, Sox2’s role in gastric cancer remains controversial. Forports 16, 1929–1941, August 16, 2016 ª 2016 The Author(s). 1929
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example, some reports have found a positive correlation be-
tween SOX2 expression and gastric cancer progression in pa-
tients, consistent with a tumor-promoting role of SOX2 (H€utz
et al., 2014; Matsuoka et al., 2012). However, independent
studies noticed a downregulation of SOX2 expression with
gastric cancer progression indicative of a possible tumor sup-
pressor function (Otsubo et al., 2008, 2011; Wang et al., 2015;
Zhang et al., 2010).
To better understand the mechanisms by which Sox2 expres-
sion may contribute to stomach homeostasis and cancer, we
sought to determine its functions in the normal and malignant
gastric epithelium using a loss-of-function mouse model, as well
as an in vitro organoid system.We also have usedmousemodels
to assess the susceptibility of Sox2+ stem/progenitor cells to
initiate tumors and employed genome-wide approaches to define
downstream targets of Sox2 in gastric epithelial cells relative to
other Sox2-expressing stem and progenitor cell populations.
RESULTS
Sox2 Occupies Loci Related to Endoderm Development
and Gastric Cancer
Using a fluorescent knockin reporter and genetic lineage tracing,
we previously showed that Sox2 expressionmarks rare epithelial
cells in the glandular stomach that function as somatic stem cells
(Arnold et al., 2011). The same stem cells could be visualized by
immunohistochemistry (IHC) with a Sox2-specific antibody,
which we confirmed in this study (Figures S1A and S1B).We pre-
viously deemed the rarity of Sox2+ cells to be incompatible with
assays to interrogate genome-wide targets of Sox2 using ChIP-
seq analysis. However, when we re-examined Sox2 expression
patterns in the antrum with two novel Sox2 antibodies, we de-
tected not only this rare population of Sox2high cells but also a
more abundant population of Sox2low cells surrounding the
stem cells and coinciding with the proliferative progenitor cell
compartment (Figure 1A, S1A, and S1B). In situ hybridization
confirmed that Sox2 is expressed as a gradient in gastric epithe-
lial cells with a discernible population of Sox2high cells (Fig-
ure S1C). This finding is reminiscent of a continuous, but weak,
expression of stem cell markers across progenitor cell popula-
tions in the brain and intestine (Hagey and Muhr, 2014; Mun˜oz
et al., 2012). We therefore reasoned that the observed Sox2
expression gradient in stomach glands might allow us to procure
sufficient material to examine Sox2 targets in the gastric stem
and progenitor cell compartment by using ChIP-seq analysis.
We performed ChIP-seq on isolatedmouse gastric glands from
wild-type mice and mapped more than 7,000 high-confidence
binding sites (Figures S2A and S2B). Consistent with Sox2’s
role as a transcriptional regulator, 15% of sites mapped to pro-
moters (0–3 kb upstream of transcription start sites [TSSs]), and
roughly 80% of sites mapped to intergenic regions and introns,
which typically contain enhancers (Figure 1B). Bound sites were
highly enriched for the classical Sox consensus motif ACAAAG
(93% of all sites), implying direct occupancy of most sites (Fig-
ure 1C). Gene ontology (GO) analysis using the GREAT algorithm
revealed enrichment of genes related to digestive tract, foregut
morphogenesis, and epithelial differentiation among regulatory
regions (Figure 1D, left). In agreement with these enriched cate-1930 Cell Reports 16, 1929–1941, August 16, 2016gories, we detected Sox2 binding near key regulatory genes pre-
viously associated with endoderm development and gut differen-
tiation, including Gata6 and Cdx2 (Figure 1E; Table S1) (Zorn and
Wells, 2009). Of interest, Sox2 binds to its own promoter in the
stomach, suggesting an autoregulatory feedback mechanism
akin to ESCs and NPCs (Boyer et al., 2005; Lodato et al., 2013)
(Figure 1E). In addition to targets associated with differentiation
and development, GREAT analysis showed overrepresentation
of processes related to gastric disease, such as increased GI
tumor incidence and abnormal stomach epithelium (Figure 1D,
left). We further observed enrichment for signaling pathways
mutated in gastric cancer, such as components of the Akt,
ErbB2, Vegf, and Wnt cascades (Figure 1D, right).
Notably, Sox2 binding sites in the stomach mucosa showed
hardly any overlap with binding sites previously identified in mu-
rine NPCs and ESCs (Figure 1F) even though the same antibody
was used for ChIP-seq analysis (Engelen et al., 2011; Marson
et al., 2008). This observation suggests that Sox2 is directed to
tissue-specific genes by associating with cell-type-specific co-
factors, similar to observations in NPCs and ESCs (Sarkar and
Hochedlinger, 2013). Consistently, genomic regions adjacent
to Sox2 binding sites were enriched for motifs recognized by
the glandular stomach-expressed transcription factors Foxa2
(69% of all Sox2 targets), Klf4 (60%), Jun (35%), and Gata6
(32%), which may confer target gene selectivity (Figure 1G,
top). Expression patterns of Klf4 and Gata6 in the gastric epithe-
lium partially overlapped with those of Sox2 expression, further
suggesting co-regulation of targets by these factors (Figure 1G,
bottom). Altogether, these data reveal that Sox2 occupies target
genes related to endoderm development, stomach function, and
gastric cancer and that there is little overlap with Sox2 binding
sites in ESCs and NPCs.
Sox2 Is Dispensable for Normal Stomach Homeostasis
Given that Sox2 occupies loci associated with endoderm
development and epithelial differentiation, we next determined
whether Sox2 itself is required during adult stomach homeosta-
sis. Toward this end, we generated a conditional knockout (KO)
allele, Sox2fl, using conventional gene targeting (Figures 2A and
2B) and crossed homozygous Sox2fl/fl mice with mice express-
ing tamoxifen-inducible Cre recombinase from the ubiquitously
expressed Rosa26 locus (Rosa26CreER). We then gave 6-week-
old Rosa26CreER; Sox2fl/fl mice tamoxifen to induce Cre-medi-
ated excision of Sox2 and sacrificed animals at different times
(Figure 2C); we refer to these animals as Sox2 KO mice and
wild-type controls as Sox2 WT mice. The glandular stomach in
Sox2 KO animals displayed near-complete loss of Sox2 by
RNA and protein analysis (Figure 2D, left), indicating high loop-
out efficiency. Furthermore, ChIP-seq analysis for Sox2 on
gastric glands isolated from tamoxifen-induced Sox2 KO ani-
mals mapped only a few targets compared to binding sites de-
tected in Sox2WT gastric glands (Figures S2A andS2B), demon-
strating the absence of chromatin-associated Sox2 protein in
Sox2 KO mice and confirming the specificity of our Sox2 ChIP
assay (Figure 1). We presume that the residual ChIP-seq signal
in Sox2 KO samples is due to inefficient loopout.
Surprisingly, we observed no obvious morphological changes
in the glandular stomach, even weeks or several months after
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Figure 1. Sox2 Occupies Genomic Loci Related to Endoderm Development and Gastric Cancer
(A) IHC for Sox2 and scheme to perform Sox2 ChIP-seq on antrum using R&D antibody.
(B) Pie-chart showing the distribution of Sox2 binding sites across the genome.
(C) The canonical Sox2 sequencemotif is themost enriched (Z score:52; p < 0.001) among Sox2 ChIP-seq bound sites (4,631 out of 5,000 total) in antral glands.
(D) GO analysis for categories enriched in ChIP-seq dataset from stomach glands. x axis reflects negative log base 10 of binomial raw p value for enrichment
versus a whole-genome background. Numbers to right indicate genes in category.
(E) Wiggle tracks from ChIP-seq on wild-type (WT) and Sox2 KO (control, CTR) antrum.
(F) Venn diagram representing overlap of Sox2 occupancy in neural progenitor cells (NPCs), embryonic stem cells (ESCs), and stomach progenitor cells.
(G) Top: enriched sequence motifs for Klf4 and Gata6 found within 600 bp of Sox2-bound sites (Z score: 24 for Klf4 and 27 for Gata6; p < 0.001 for both).
Bottom: IHC for Sox2, Klf4, and Gata6. Z score and number of hits (number of Sox2-bound sites) are listed. Dotted line indicates area of Sox2 expression.
See also Figure S1 and Table S1.Sox2 deletion (Figure 2E). Consistently, the gastric epithelium
of both Sox2 WT and KO mice contained the expected pattern
of proliferative (Ki67+) progenitors and differentiated cells,
including enteroendocrine (Gastrin+) and secretory (Muc5AC+)cells (Figure 2F). To probe Sox2’s function in gastric epithelial
regeneration and differentiation independently, we generated
organoids, which self-renew and differentiate in culture (Barker
et al., 2010), recapitulating gastric cell behaviors in vitro.Cell Reports 16, 1929–1941, August 16, 2016 1931
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Figure 2. Sox2 Is Dispensable for Stomach Homeostasis
(A) Targeting strategy to generate Sox2fl/fl ESCs and mice. Restriction sites, Southern blot probes and expected restriction fragment lengths are indicated.
(B) Southern blot analyses with 50 and 30 probes to verify correct targeting in ESCs.
(C) Breeding strategy to generate Sox2 KO and control animals.
(D) Top: western blot analyses on tamoxifen induced Sox2 WT and KO antrum. Bottom: Expression of Sox2 in tamoxifen induced Sox2 WT and KO antrum and
organoid samples using RNA-seq analysis. FDRs (false discovery rates) are listed. Abbreviations: st, stomach; org, organoid.
(E and F) Immunohistochemistry for Sox2, Gastrin, Muc5AC and Ki67 on antrum isolated from Sox2 WT and KO mice 18 months after tamoxifen induction.
(G) Sample bright-field images of Sox2 KO organoids four passages after treatment with EtOH (control) or 4-OHT (Sox2 KO).
(H) Organoid diameter measurements in control and Sox2 KO organoid lines (n = 25; p = 0.0920; t test) four passages after EtOH and 4-OHT treatment.
(I) Venn diagram representing overlap between differentially expressed genes (RNA-seq; fold change > 2; FDR < 0.05) and genes with Sox2 occupancy within 10
kb of the TSS (ChIP-seq) when comparing Sox2 WT and KO antrum.
(J)MAplot highlightingdifferentially expressedgenes (red; fold change>2; FDR<0.05) and gastricdifferentiationmarkers (purple) betweenSox2WTandKOantrum.
(K) Expression of Sox factors in Sox2 WT and KO antrum 2 weeks after tamoxifen induction.
See also Figure S2 and Tables S2 and S3.
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Organoids cultured from Rosa26CreER; Sox2fl/fl gastric glands
and treated with 4-hydroxytamoxifen lost Sox2 RNA and protein
expression (Figure 2D, right panels), yet showed morphology
and growth similar to solvent-treated or 4-OHT-treated control
organoids (Figures 2G and 2H). Other tissues that reportedly
contain Sox2+ cells (e.g., lung, uterus, and anus) also lacked
overt abnormalities and we observed no excess mortality in
Sox2 KO mice (data not shown). Thus, Sox2 is dispensable for
viability, gastric epithelial regeneration and differentiation, in
striking contrast to its essential roles during development (Avilion
et al., 2003; Que et al., 2007; Sarkar and Hochedlinger, 2013).
To determine whether loss of Sox2 in the stomach epithelium
results in any measurable transcriptional dysregulation, we per-
formed RNA sequencing (RNA-seq) of gastric glands isolated
from the antrum of Sox2 WT (n = 3) and Sox2 KO (n = 3) animals.
We detected 59 genes that were dysregulated more than 2-fold
in Sox2 KO stomachs compared to WT stomachs (42 upregu-
lated and 17 downregulated genes; p < 0.05) (Figures 2I and
2J; Table S2). GO analysis showed that differentially expressed
genes are involved in extracellular functions, signaling, and
secretion (data not shown). Of note, 17% (10/59) of dysregulated
genes had nearby Sox2 binding sites (±10 kb from the TSS),
suggesting direct regulation by Sox2 (e.g., Trerf1, Itln1, and
Atp6v0d2) (Figure 2I). Moreover, six of the Sox2 targets were up-
regulated, while four of the Sox2 targets were downregulated in
Sox2 KO antrum, implying that Sox2 contributes to both gene
activation and repression (Table S3). However, only 0.5% (10/
2,121) of all TSS-associated Sox2 peaks were transcriptionally
dysregulated, which raises the possibility that other Sox family
transcription factors may compensate for the absence of Sox2
(Figure 2I). Indeed, we detected RNA expression of Sox4,
Sox9, Sox13, Sox18, and Sox21 in the antrum of WT mice,
although none of these factors were upregulated in Sox2-defi-
cient mice (Figures 2K and S2C). These data show that loss of
Sox2 in the gastric epithelium results in only modest transcrip-
tional changes, and this is not accompanied by compensatory
upregulation of other Sox factors.
Rapid and Widespread Adenoma Formation from Sox2+
Gastric Cells
Because our ChIP-seq analysis also revealed Sox2 occupancy
at a number of genes implicated in cell proliferation and stom-
ach cancer, we considered that Sox2+ cells might serve as a
source for gastric tumors. To test this hypothesis, we targeted
the Wnt pathway by acutely inactivating Apc, the tumor sup-
pressor and inhibitor of b-catenin, in Sox2+ cells. APCmutations
are present in up to one-third of human gastric cancers (Cer-
vantes et al., 2007) and mice heterozygous for an Apc mutation
(ApcMin) develop adenomas in the antrum of the stomach
through loss of heterozygosity (Tomita et al., 2007). We crossed
Apcfl/fl mice with mice carrying both a tamoxifen-inducible Cre
allele in the endogenous Sox2 locus (Sox2CreER) and a
loxP-flanked EYFP reporter in the Rosa26 locus (Sox2CreER;
Rosa26lslYFP) (Figure 3A). To avoid compromised viability as a
result of Apc deletion in other Sox2-expressing tissues, we
delivered tamoxifen (1 dose of 1 mg) locally by oral gavage (Fig-
ure 3A) and verified deletion of Apc in Sox2+ cells through the
appearance of small groups of cells with elevated levels ofnuclear b-catenin 3 days later (Figures 3B and S3A). These
b-catenin+ cells replicated rapidly, forming multiple micro-ade-
nomas within 1 month and large adenomas within 1 year (Fig-
ures 3B and 3C). However, these lesions did not progress to
invasive adenocarcinomas over the course of 1 year (n = 2),
suggesting that additional events are necessary for tumor pro-
gression. Adenomas expressed the EYFP reporter (Figure 3D),
confirming that they originated from Sox2+ cells. Moreover, tu-
mors continued to express Sox2, implying the presence of cells
with stem/progenitor cell characteristics (Figure 3E). Collec-
tively, these data demonstrate that Sox2+ cells are potent cells
of origin in a Wnt-driven gastric tumor model.
Lgr5 expression identifies a cell population at the very base of
gastric glands, which also contains stem cells and gives rise to
adenomas in an Apc-dependent tumor model (Barker et al.,
2010; Radulescu et al., 2013). To compare the efficiency of tumor
formation from Lgr5+ and Sox2+ cells, we crossed Sox2CreER
mice or Lgr5GFP-IRES-CreER mice to Apcfl/fl mice, treated double-
transgenic animals with tamoxifen and scored tumor formation
4 weeks later (Figure 3F). Remarkably, we detected 10 times
more adenomas in Sox2CreER, Apcfl/fl mice compared to
Lgr5GFP-IRES-CreER, Apcfl/fl mice (Figures 3G and 3H). However,
since Sox2CreER and Lgr5GFP-IRES-CreER mice appear to exhibit
different loopout efficiencies (Figure S3C), we cannot exclude
that increased tumor numbers in Sox2CreER, Apcfl/flmice is partly
due to Apc deletion in more stem or progenitor cells. In contrast
to induced Sox2CreER, Apcfl/fl animals, Lgr5GFP-IRES-CreER, Apcfl/fl
mice that developed gastric adenomas could not be analyzed
beyond 3–4 weeks post-tamoxifen treatment because of a
significant intestinal tumor burden that required us to sacrifice
animals. Altogether, our data identify Sox2CreER, Apcfl/fl mice
as a useful gastric tumorigenesis model since they produce
more adenomas that can be examined for a longer period of
time compared to Lgr5GFP-IRES-CreER, Apcfl/fl mice.
Sox2 Loss Enhances Gastric Tumorigenesis
Next, we revisited the functional role of Sox2 in gastric tumori-
genesis since previous reports are conflicting. We performed
immunohistochemistry for SOX2 on 18 human gastric adenocar-
cinoma specimens and matching normal human gastric mucosa
samples. We detected SOX2+ cells at the base of human
gastric glands in the antrum, recapitulating expression patterns
observed in mouse stomach (Figure 4A). However, SOX2
expression was either absent or extremely low in 13 out of 18
gastric tumors (Figure 4A; Table S4), suggesting that SOX2
silencing rather than SOX2 overexpression may be selected for
during for gastric cancer progression. To corroborate this notion,
we reanalyzed publicly available expression and epigenetic data
collected from over 300 gastric cancer specimens (Cancer
Genome Atlas Research Network, 2014). While there was no ev-
idence for SOX2mutations in this dataset, we found that gastric
tumors of the microsatellite instability (MSI) subtype (Cancer
Genome Atlas Research Network, 2014), which are most preva-
lent in the antrum, showed reduced SOX2 expression and
increased DNA methylation at the SOX2 locus relative to normal
tissue or other gastric cancer subtypes (p < 0.05) (Figures 4B and
4C). These results are consistent with our histological observa-
tions of human specimens and thus strengthen the interpretationCell Reports 16, 1929–1941, August 16, 2016 1933
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Figure 3. Efficient Tumor Formation following Wnt-Driven Transformation of Adult Sox2+ Gastric Cells
(A) Breeding strategy to determine tumor-initiating potential of Sox2+ cells.
(B) IHC for b-catenin in Apc KO antrum 3 days, 1 month, and 7 months after tamoxifen induction. Arrows point to cells or tumors with nuclear accumulation of
b-catenin. Blue dotted line highlights microadenoma.
(C) Stomachs from ApcWT and Apc KOmice 1month and 1 year after tamoxifen induction. Arrow indicates enlarged antrum in Apc KO stomach. Blue dotted line
highlights large tumors in antrum of Apc KO stomach.
(D and E) IHC for YFP (D) and Sox2 (E) on adenoma from Apc KO antrum 7 months after tamoxifen induction.
(F) Breeding strategy to compare tumor-initiating potential of Sox2+ and Lgr5+ cells.
(G) Quantification of adenomas developing in Lgr5CreER and Sox2CreER mice 1 week (p = 0.0006; t test) and 1 month (p < 0.0001; t test) after tamoxifen induction.
(H) IHC for b-catenin in Lgr5CreER and Sox2CreER antrum 1 week after induction. Abbreviations: FS, forestomach; C, corpus; A, antrum; I, intestine.
See also Figure S3.
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Figure 4. Sox2 Loss Enhances Wnt-Driven Adenomagenesis
(A) IHC for SOX2 on normal human stomach and stomach adenocarcinoma.
(B) Expression of SOX2 in human gastric cancer subtypes (p < 0.05, Kruskal-Wallis test).
(C) Methylation of SOX2 locus in human gastric cancer subtypes CIN, EBV, GS, and MSI (p < 0.05, Kruskal-Wallis test).
(D) Breeding strategy to study role of Sox2 in Wnt-driven adenomagenesis.
(E) IHC for b-catenin and Sox2 in Apc KO and DKO mice 1 month after tamoxifen induction.
(F) Bright-field images of organoids isolated from adult Apc KO and DKO mice and treated with 4-OHT.
(G) Quantification of adenomas in Apc KO and DKO mice 1 month after tamoxifen induction (n = 11 for Apc KO mice; n = 14 for DKO mice; p = 0.03; t test).
(H) Organoid repopulation potential of Apc KO and DKO organoid lines treated with 4-OHT (n = 3 organoid lines; p = 0.007; t test).
See also Figure S4 and Table S4.that epigenetic silencingmay be a commonmechanism to atten-
uate SOX2 expression during gastric tumorigenesis within the
antrum.
To directly test the functional consequence of Sox2
expression on gastric tumorigenesis, we mated Sox2fl/fl mice
to Sox2CreER; Apcfl/fl animals to generate Apc knockout (Apc
KO) and Apc/Sox2 double-knockout (DKO) mice (Figure 4D).
We observed adenoma formation with nuclear accumulation of
b-catenin in both Apc KO and DKO mice (Figure 4E) and loss
of Sox2 specifically in DKO adenomas (Figures 4E and S3B).
Notably, we detected a 3-fold increase in the number ofadenomas in tamoxifen treated DKO mice compared to Apc
KO mice, which is in agreement with the observation that
SOX2 expression inversely correlates with human gastric cancer
growth (Figures 4E and 4G). To confirm this result by indepen-
dent means, we generated gastric organoids from these animals
and observed again a 3-fold increase in the number of organoids
that grew after 4-hydroxytamoxifen treatment of DKO cultures
compared to Apc KO cultures (Figures 4F and 4H). These results
suggest that SOX2 functions as a context dependent tumor sup-
pressor rather than an oncogene during Wnt-driven adenoma-
genesis in the antrum of the glandular stomach.Cell Reports 16, 1929–1941, August 16, 2016 1935
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Figure 5. Sox2 Restrains Wnt Signaling in
Apc-Deficient Gastric Cells
(A) Centrimo plot showing centralized enrichement
of Tcf motifs near peaks from Sox2 ChIP-seq data.
(B) Wiggle tracks of genes associated with Wnt
signaling based on Sox2 ChIP-seq data of Sox2WT
and KO antrum.
(C) Overview of Wnt reporter assay.
(D) Luciferase activity in LV-7x-Tcf-Ffluc/PuroR-in-
fected organoids (n = 2 biological lines; 3 technical
replicates, p < 0.001; t test).
(E) Expression and methylation of SOX2 in normal
tissue and human gastric cancers with mutations in
WNT component genes RNF43, APC, or CTNNB1
(p values from Wilcoxon test).
(F) Western blot analyses of LV-Teto-Sox2; LV-rtTA;
LV-7x-Tcf-Ffluc/PuroR-infectedHUG1N andSNU-1
lines grown with or without doxycycline (dox).
(G) Luciferase activity of LV-Teto-Sox2; LV-rtTA; LV-
7x-Tcf-Ffluc/PuroR-infected HUG1N and SNU-1
lines grown with or without doxycycline (dox) (n = 3
technical replicates; p < 0.0001; t test).Sox2 Restrains Wnt Signaling in Apc-Deficient Gastric
Cells
The above-mentioned findings raise the possibility that Sox2
may interfere directly with expression of Wnt/b-Catenin target
genes, providing a plausible explanation for increased tumori-
genesis in the absence of Sox2. In agreement with this idea,
we found local co-enrichment of motifs recognized by Tcf3/
Tcf4 and Sox2 within our Sox2 ChIP-seq peaks (Figures 5A
and S4A); Tcf proteins are effectors of canonical Wnt/b-catenin
signaling. The observed enrichment for Tcf motifs appears to
be specific since Smad2 sites, which respond to the unrelated
Bmp signaling pathway, are rarely found next to Sox2 targets
even though both Smad2 and Tcf3/Tcf4 are abundantly ex-1936 Cell Reports 16, 1929–1941, August 16, 2016pressed in the gastric epithelium (data
not shown). In addition to the overall co-
enrichment of Tcf and Sox2 sites, we
found that Sox2 occupies several key
genes involved in the Wnt/b-catenin
cascade, including Tcf4, Apc, and Ctnnb1
(Figure 5B; Table S1). These data suggest
that gastric Wnt targets and Sox2 targets
may be co-regulated globally.
To functionally support the hypothesis
that Sox2 suppresses Wnt/b-catenin
signaling, we determined expression of
the Wnt target Lgr5 in the antrum of Sox2
WT, Sox2 KO, Apc KO, and DKO mice
using in situ hybridization (Figure S4B).
Although we were unable to detect differ-
ences in Lgr5 expression between Sox2
KO and WT stomachs, DKO mice showed
a trend for increased Lgr5 signal
compared to Apc deficient mice. This
observation suggests that Sox2 sup-
presses Wnt-responsive genes specif-
ically in the context of Apc-dependentWnt activation. Attempts to confirm this result by global gene
expression analysis of Sox2 KO and DKO tissue was unsuccess-
ful because of the heterogeneity of DKO tumors relative to Sox2
KO epithelium. We therefore performed an alternative lentivirus-
based Tcf/Lef reporter assay (Fuerer and Nusse, 2010) by using
organoids derived from Sox2 WT, Sox2 KO, Apc KO and DKO
mice. Organoids infected with this lentivirus were first selected
in puromycin to ensure homogeneous expression of the reporter
construct, followed by analysis of luciferase activity. While Tcf/
Lef transcriptional activity was comparable between Sox2 WT
and Sox2 KO organoids, consistent with the absence of homeo-
static defects in Sox2 KO mice, we observed 10-fold higher Tcf/
Lef activity in Apc KO organoids and 25-fold increase in DKO
organoids (Figure 5D). These findings further suggest that Sox2
suppresses tumorigenesis, at least in part, by restraining hyper-
activated Wnt signaling in the context of an Apc mutation.
Considering that genetic loss ofSox2 leads to hyperactiveWnt
signaling in Apc-deficient gastric cells in mouse, we reasoned
that epigenetic silencing of SOX2 might be common in human
gastric cancers with hyperactive WNT signaling. We therefore
reanalyzed the SOX2 expression and DNA methylation status
across gastric tumors harboring mutations in genes that activate
WNT/b-catenin signaling including RNF43, CTNNB1, and APC
(Cancer Genome Atlas Research Network, 2014). This analysis
indeed revealed reduced SOX2 expression and increased
SOX2 methylation across all examined gastric cancer samples
harboring mutations in RNF43 (p < 0.05 for expression; p <
0.05 for methylation) and a similar trend in samples harboring
mutations in CTNNB1 (p = 0.12; p = 0.31) or APC (p = 0.09;
p = 0.15) (Figure 5E), although this was not significant. These re-
sults show that SOX2 tends to be epigenetically and transcrip-
tionally silenced in human gastric tumors with WNT-activating
mutations, suggesting that SOX2 may suppress Wnt signaling
not only in mouse but also in human gastric tumor cells.
To assess whether SOX2 expression is sufficient to attenuate
WNT signaling in human gastric cells carrying mutations in com-
ponents of WNT pathway, we compared Tcf/Lef reporter activity
between a gastric cancer cell line harboring a homozygous APC
mutation (HUG1N) and a gastric cancer cell line with no known
mutations in the WNT pathway (SNU-1) (Barretina et al., 2012).
Briefly, we transduced these cell lines with separate lentiviral
vectors carrying the Tcf/Lef reporter, a doxycycline-inducible
SOX2 transgene and the rtTA transactivator. Transgenic SOX2
induction in these lines was confirmed by western blot analysis
before measuring reporter activity (Figure 5F). As expected,
HUG1N cells produced a robust reporter signal whereas
SNU-1 cells produced only basal reporter signal in the absence
of doxycycline (Figure 5G). However, doxycycline exposure of
HUG1N cells reduced Tcf/Lef activity by 2- to 3-fold, whereas
it had no effect on reporter activity in SNU-1 cells (Figure 5G).
These data complement our results on Sox2 KO organoids in
mouse and provide supportive evidence that SOX2 expression
restrains Tcf/Lef activity in a well-characterized human gastric
cell line with activated WNT signaling.
Sox2 Modulates Intestinal and Metaplasia-Associated
Genes
We next wondered whether Sox2 interferes with other aspects of
gastric tumorigenesis beyond its role in Wnt/b-catenin signaling.
Intestinal metaplasia of the stomach epithelium is considered to
be a precursor lesion to gastric cancer and involves the upregula-
tion of intestinal genes and the silencing of gastric genes. As
epigenetic silencing of SOX2 coincides with intestinal metaplasia
(Camilo et al., 2015; Tsukamoto et al., 2004) and precedes gastric
cancer in patients, we wondered whether Sox2 might be directly
involved in maintaining the gastric expression program and sup-
pressing the intestinal expression program. While we did not
detect major transcriptional changes in the Sox2 KO stomach
(Figure 2J), closer inspection of the dysregulated genes re-
vealed an association with intestinal biology and metaplasia. For
example, the gene Intelectin1 (Itln1), which is expressed in intes-tinal goblet cells and intestinal metaplasia (Zheng et al., 2012) but
absent in the normal gastric mucosa, was upregulated 45-fold in
Sox2-deficient gastric tissue (Figures 6A and S5A). We also
observed ectopic expression of the intestinal mucin Zg16 and
the colon-expressed lysosomal H+ transporting ATPase subunit
Atp6v0d2, which has been associated with gastric cancer (Fuka-
machi et al., 2014), in Sox2 KO stomach samples (Figure 6A).
Conversely, we detected reduced expression in Sox2 KO stom-
ach of Gsdmc2, Gsdmc3, andGsdmc4, members of the gasder-
min family of genes (Figurea 6B and S5A), which are frequently
silenced in intestinal type gastric cancers (Saeki et al., 2007).
To probe whether Sox2-deficient gastric cells activate other,
more established markers of intestinal identity, we examined
the expression status of the intestinal epithelial marker Cdx2 as
well as the intestinal stem cell marker Olfm4. Indeed, we noticed
amodest upregulation of both genes in 2 of 3 examined Sox2 KO
antrum samples (Figure S5B), although the differences were not
statistically significant. However, when we analyzed these intes-
tinal markers in our gastric organoid system, we observed a pro-
nounced increase in Olfm4 RNA levels in the Sox2 KO sample
compared to a wild-type control (Figure 6C). Of note, Olfm4
expression has also been associated with intestinal metaplasia
and its suppression in established gastric cancer cell lines report-
edly attenuates cell growth (Jang et al., 2015; Liu et al., 2012). To
confirm upregulation of Olfm4 upon Sox2 loss with an indepen-
dent assay, we generated a viral construct containing an EGFP
reporter driven by a 1,168 bp fragment containing theOlfm4 pro-
moter. We detected increased Olfm4-EGFP expression in Sox2
KO organoids compared to control organoids by both live fluo-
rescence (Figure 6D) and flow cytometry (Figure 6E), thus sup-
porting the conclusion that this marker of intestinal stem cells
and early stages of gastric cancer is activated upon Sox2 loss.
Finally, we determined whether genes upregulated in the Sox2
KO stomach are also elevated in human gastric cancer. Indeed,
we found a significant increase of OLFM4 and ATP6V0D2 levels
in stomach cancer samples compared to normal tissue (Fig-
ure 6F). Collectively, these results suggest that Sox2 depletion
may contribute to tumorigenesis not only by activating Wnt
signaling but also by derepressing a subset of genes associated
with intestinal homeostasis and metaplasia (Figure 7).
DISCUSSION
We have dissected the molecular and functional roles of Sox2
and Sox2-expressing cells in gastric epithelial homeostasis
and tumorigenesis. A main conclusion of our study is that Sox2
is dispensable for normal tissue renewal in the adult glandular
mouse stomach. This result was unexpected in the light of
Sox2’s requirements in embryonic development and mainte-
nance of other types of stem cells such as ESCs, NSCs and
trophoblast stem cells (Sarkar and Hochedlinger, 2013). We sur-
mise that other Sox proteins can compensate in the absence of
Sox2. Considering that several other Sox familymembers are ex-
pressed in the glandular stomach, it will be interesting to assess
the consequence of their combined loss in the normal gastric
epithelium. For example, we expect that co-deletion of Sox2
and Sox9 might exert a homeostatic phenotype given that
Sox9 is also expressed in the progenitor cell compartment ofCell Reports 16, 1929–1941, August 16, 2016 1937
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Figure 6. Sox2 Modulates Intestinal and
Metaplasia-Associated Genes
(A) Upregulation of genes in Sox2 KO antrum that
have been associated with intestinal biology and
intestinal metaplasia.
(B) Downregulation of genes in Sox2 KO antrum
that have been associated with intestinal meta-
plasia.
(C) Expression of intestine-specific genes Cdx2
and Olfm4 and gastric-specific gene Sox2 in con-
trol (EtOH-treated) and Sox2 KO (4-OHT treated)
organoids (n = 2 biological replicates).
(D and E) Control and Sox2 KO organoids infected
with Olfm4-GFP reporter and analyzed after two
passages by fluorescent microscopy (D) and flow
cytometry (E).
(F) Expression of SOX2, OLFM4, and ATP6V0D2
in normal human stomach and gastric cancer
(p values from Wilcoxon test).
See also Figure S5.the stomach and its loss in the intestinal epithelium reportedly
causes crypt hyperplasia and secretory cell defects by deregu-
lating Wnt signaling (Blache et al., 2004; Mori-Akiyama et al.,
2007; Sinner et al., 2007).
Our mouse models also allowed us to revisit the cellular origin
of gastric tumors, which remains elusive. Although loss of the
Apc tumor suppressor in Lgr5+ gastric stem cells gives rise to
isolated adenomas within a few weeks (Barker et al., 2010), their
potential to progress could not be evaluated owing to the over-
growth of intestinal tumors. In contrast, our data identify Sox2-
expressing gastric epithelial cells as an efficient source of Wnt-
driven tumors, giving rise to multiple micro-adenomas that
grow substantially over many months. As these animals survive
for over a year, our mouse model may represent a useful system
to study early events in tumorigenesis and to identify facilitators1938 Cell Reports 16, 1929–1941, August 16, 2016of gastric cancer progression. It will be
important to test in the future whether
qualitative and/or quantitative differ-
ences between Lgr5+ and Sox2+ gastric
cells underlie increased adenoma forma-
tion in Sox2CreER, Apcfl/fl mice relative to
Lgr5GFP-IRES-CreER, Apcfl/fl mice.
The presented data further help to clarify
the functional role ofSox2 in gastric tumor-
igenesis, which remains controversial. We
conclude that Sox2 acts as a tumor sup-
pressor by restraining the growth of Apc
mutant cells in vivo and in vitro. This finding
was also unexpected because SOX2 am-
plifications and overexpression are gener-
ally associated with tumor progression in
the esophagus, lungs, retina, skin, and pi-
tuitary. However, our results are consistent
with previous reports, which showed that
SOX2 expression is reduced during gastric
cancer development in patients (Otsubo
et al., 2008; Wang et al., 2015; Zhanget al., 2010), andwe confirmed this observation herewith an inde-
pendent set of primary humangastric tumors, aswell as a recently
publishedcollectionof over 300cancer samples (CancerGenome
Atlas Research Network, 2014). The recent finding that Sox2 het-
erozygosity leads to a 15-fold increase in papillary tumors origi-
nating from bronchiole cells suggests that Sox2 may function as
a tumor suppressor in other tissues aswell (Xu et al., 2014). These
results indicate that Sox2’s effect on cell proliferation and tumor-
igenesis is highly context dependent.
Our data suggest that Sox2 loss influences gastric tumorigen-
esis by at least two mechanisms. First, Sox2 seems to limit cell
proliferation and tumor growth by dampening hyperactivate
Wnt/b-catenin signaling, as in Apc mutant cells. This link be-
tween Sox factors and Wnt/b-catenin activity is supported by
previous reports in alternative systems (Blache et al., 2004;
Figure 7. Summary and Model of Sox2’s
Role in Stomach Homeostasis and Wnt-
Driven Tumorigenesis
Under homeostatic conditions, Sox2 is dispens-
able for gastric stem cell self-renewal and epithe-
lial turnover. Downregulation of Sox2may promote
tumorigenesis in the context of Wnt activation by
at least two parallel mechanisms. First, Sox2
functions as a tumor suppressor by inhibiting Wnt
signaling through its repressive effect on Tcf/Lef
dependent targets. Second, Sox2 loss primes
gastric cells for intestinal metaplasia by de-re-
pressing intestinal genes.Hagey and Muhr, 2014; Kormish et al., 2010). Second, Sox2 loss
may contribute to tumorigenesis by derepressing a subset of
genes associated with intestinal identity including the stem cell
marker Olfm4. Critically, several of these genes are dysregulated
in gastric intestinal metaplasia. We surmise that these transcrip-
tional changes prime gastric cells for increased tumor growth
in vitro and in vivo once potent tumor suppressors such as
Apc are lost. Additional work is certainly required to fully
understand the mechanisms by which Sox2 influences Wnt/
b-catenin signaling and intestinal gene expression in gastric
tumorigenesis.
Comparison of Sox2 target genes in different stem cell popu-
lations is important for understanding how the same transcrip-
tion factor achieves such functional versatility. Surprisingly, the
vast majority of Sox2 targets differ between gastric, neural,
and embryonic stem and progenitor cell populations. These
unique binding patterns are likely the consequence of cell-
type-specific cofactors that associate with Sox2 and target
distinct gene sets (Sarkar and Hochedlinger, 2013). Indeed, our
ChIP-seq data point to a small number of candidate cofactors
in the stomach, including the transcription factors Jun, Gata6,
Foxa2, and Klf4. Of note, the expression pattern of Gata6 and
Klf4 partially overlaps with that of Sox2 in the gastric epithelium,
suggesting that they may collaborate within the same cells. It will
now be interesting to test if Sox2 physically associates with
any of these proteins and co-occupies key targets in gastric
progenitors.
Altogether, our study elucidates functional andmolecular roles
of Sox2 in stomach stem and progenitor cells, yielding insights
into (1) the basis of gastric tumorigenesis, (2) molecular links be-
tween Sox2, Wnt/b-catenin signaling and intestinal cell fate, and
(3) mechanisms by which the same Sox factor may control
different target genes in distinct stem and progenitor cell popu-
lations. These data will inform efforts to manipulate gastric stem
cell populations for regenerative therapy and may lead to strate-
gies to target gastric cancer.
EXPERIMENTAL PROCEDURES
Mice
Sox2fl/fl mice were generated by homologous recombination in embryonic
stem cells using standard technology. Correctly targeted clones were in-jected into BDF1 blastocysts and transferred into pseudo-pregnant females.
The resultant chimeric mice were bred with 129SvJae mice, and germline
offspring were bred to establish stable lines. RosaCreER (Ventura et al.,
2007), Sox2CreER (Arnold et al., 2011), Lgr5GFP-Ires-CreERT2 (Barker et al.,
2010), and Apcfl/fl (Colnot et al., 2004) mice have been previously described
and were obtained from Jackson Laboratories or provided by K. Haigis. All
animal studies were carried out following the approved guidelines of the an-
imal protocol of the Massachusetts General Hospital Cancer Center.
Treatments of Mice
All treatments were initiated on adult 6- to 8-week-old mice. RosaCreER;
Sox2 fl/fl mice were injected intraperitoneally with 1 mg of tamoxifen (Sigma)
for five consecutive days. All other mice were administered a single dose of
1 mg tamoxifen by oral gavage.
Tissue Preparation and Immunohistochemistry
Mouse tissues were harvested, fixed in 10% formalin overnight, and then pro-
cessed for IHC. Human tissues were obtained and prepared as previously
described (Sulahian et al., 2014). H&E and IHC stains were preformed using
standard procedures. For antibody descriptions, see the Supplemental Exper-
imental Procedures.
ChIP Sequencing and RNA Sequencing
For details, see the Supplemental Experimental Procedures.
Organoid Culture and Reporter Assays
For details, see the Supplemental Experimental Procedures.
Statistical Analysis
Data analysis and graph generation were performed using GraphPad Prism
(v.6) (GraphPad Prism Software). Statistics for all mouse and organoid exper-
iments were analyzed using Student’s t test, as indicated in figures. Data are
displayed as mean ± SD. n is the number of biological replicates unless other-
wise specified. Human gastric tumor data were analyzed using the Wilcoxon
signed-rank test.
ACCESSION NUMBERS
The accession number for the RNA-seq and the ChIP-seq data reported in this
paper is GEO: GSE83966.
SUPPLEMENTAL INFORMATION
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five figures, and four tables and can be found with this article online at
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